A peptide aptamer is a selected peptide ligand that binds a specific protein, typically through a variable amino acid sequence constrained within a stable protein scaffold [1][2]. In the original system, twenty-residue sequences were inserted into the exposed active-site loop of Escherichia coli thioredoxin, and a yeast two-hybrid screen identified variants recognizing cyclin-dependent kinase 2 [1]. The scaffold restricts the conformations available to the displayed sequence while supporting its intracellular expression. Selection links a binding phenotype to the DNA encoding the ligand, allowing individual aptamers to be recovered and characterized [1][2]. Binding can interfere with a target's catalytic activity or molecular interactions, providing a means to perturb protein function without eliminating the protein itself [3][4]. Specificity tests distinguish recognition of the intended target from binding to related proteins or assay components [2]. Biologically active aptamers can support target validation and identify interaction surfaces for subsequent small-molecule screening, including assays in which compounds displace the bound aptamer [4].
Peptidase Inhibition and Analysis • Oncology • Medicine • Health Sciences